BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

930 related articles for article (PubMed ID: 27156827)

  • 1. Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Tehrani DM; Zhao Y; Blaha MJ; Mora S; Mackey RH; Michos ED; Budoff MJ; Cromwell W; Otvos JD; Rosenblit PD; Wong ND
    Am J Cardiol; 2016 Jun; 117(12):1921-7. PubMed ID: 27156827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein B discordance with low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in relation to coronary artery calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Cao J; Nomura SO; Steffen BT; Guan W; Remaley AT; Karger AB; Ouyang P; Michos ED; Tsai MY
    J Clin Lipidol; 2020; 14(1):109-121.e5. PubMed ID: 31882375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study).
    Chandra A; Neeland IJ; Das SR; Khera A; Turer AT; Ayers CR; McGuire DK; Rohatgi A
    Am J Cardiol; 2015 Apr; 115(7):890-4. PubMed ID: 25661572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study.
    Quispe R; Elshazly MB; Zhao D; Toth PP; Puri R; Virani SS; Blumenthal RS; Martin SS; Jones SR; Michos ED
    Eur J Prev Cardiol; 2020 Oct; 27(15):1597-1605. PubMed ID: 31291776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).
    Mackey RH; Greenland P; Goff DC; Lloyd-Jones D; Sibley CT; Mora S
    J Am Coll Cardiol; 2012 Aug; 60(6):508-16. PubMed ID: 22796256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis.
    Degoma EM; Davis MD; Dunbar RL; Mohler ER; Greenland P; French B
    Atherosclerosis; 2013 Aug; 229(2):517-23. PubMed ID: 23591415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary calcium density in relation to coronary heart disease and cardiovascular disease in adults with diabetes or metabolic syndrome: the Multi-ethnic Study of Atherosclerosis (MESA).
    Zhao Y; Malik S; Criqui MH; Allison MA; Budoff MJ; Sandfort V; Wong ND
    BMC Cardiovasc Disord; 2022 Dec; 22(1):536. PubMed ID: 36494811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
    Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
    Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.
    Mani P; Ren HY; Neeland IJ; McGuire DK; Ayers CR; Khera A; Rohatgi A
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1(Suppl 1):S175-S179. PubMed ID: 27993539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/American College of Cardiology guidelines: the Multi-Ethnic Study of Atherosclerosis.
    Steffen BT; Guan W; Remaley AT; Paramsothy P; Heckbert SR; McClelland RL; Greenland P; Michos ED; Tsai MY
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):448-54. PubMed ID: 25477346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
    Bianchi C; Penno G; Malloggi L; Barontini R; Corfini M; Giovannitti MG; Di Cianni G; Del Prato S; Miccoli R
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):31-8. PubMed ID: 17420118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
    Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
    Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal associations of high-density lipoprotein cholesterol or low-density lipoprotein cholesterol with metabolic syndrome in the Chinese population: a prospective cohort study.
    Wang XR; Song GR; Li M; Sun HG; Fan YJ; Liu Y; Liu QG
    BMJ Open; 2018 May; 8(5):e018659. PubMed ID: 29743317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipids, lipoprotein distribution and depressive symptoms: the Multi-Ethnic Study of Atherosclerosis.
    Ong KL; Morris MJ; McClelland RL; Maniam J; Allison MA; Rye KA
    Transl Psychiatry; 2016 Nov; 6(11):e962. PubMed ID: 27898070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study.
    Wong ND; Zhao Y; Patel R; Patao C; Malik S; Bertoni AG; Correa A; Folsom AR; Kachroo S; Mukherjee J; Taylor H; Selvin E
    Diabetes Care; 2016 May; 39(5):668-76. PubMed ID: 27208374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis.
    Zhao Y; Evans MA; Allison MA; Bertoni AG; Budoff MJ; Criqui MH; Malik S; Ouyang P; Polak JF; Wong ND
    Atherosclerosis; 2019 Mar; 282():202-209. PubMed ID: 30600075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of coronary artery calcium on mortality and cardiovascular events in metabolic syndrome and diabetes among younger adults.
    Masrouri S; Shapiro MD; Khalili D; Hadaegh F
    Eur J Prev Cardiol; 2024 Apr; 31(6):744-753. PubMed ID: 38323650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.